AN UNBIASED VIEW OF FCCP

Pregnancy is often a known secondary cause of dyslipidemia, leading to a potential increase in triglyceride and LDL-C concentrations. Statin therapy is contraindicated for the duration of pregnancy resulting in limited options for dyslipidemia treatment throughout pregnancy. Substitute treatment solutions are vital to take care of elevated concent